Vasculature and kidney complications in sickle cell disease

Karl A Nath, Zvonimir S Katusic, Karl A Nath, Zvonimir S Katusic

Abstract

Recent developments in sickle cell disease include the concept of a vasculopathic state and the classification of sickle cell disease into a hemolysis-endothelial dysfunction phenotype or a viscosity-vasoocclusion phenotype. The hemolysis-endothelial dysfunction phenotype largely reflects deficiency of or resistance to nitric oxide. In addition to discussing these areas, we suggest that the hemolysis-endothelial dysfunction phenotype also reflects the instability of sickle hemoglobin, the release of heme, and the induction of heme oxygenase-1. From these perspectives the renal complications of sickle cell disease are discussed and classified.

Figures

Figure 1.
Figure 1.
Modified hemolysis-endothelial dysfunction phenotype and proposed renal pathophysiology in human SCD. Hemolysis in human SCD leads to NO scavenging by plasma hemoglobin (HbSS) and increased amounts of heme because of the instability of sickle hemoglobin. Heme is cytotoxic, thereby injuring glomerular cells and causing proteinuria and CKD. Induction of heme oxygenase-1, through the generation of carbon monoxide and other actions, induces vasodilation, and thus promotes hyperfiltration. The minus sign signifies that induction of heme oxygenase-1 can mitigate the adverse effects of heme by degrading heme and other cytoprotective effects of heme oxygenase-1.

References

    1. Herrick JB: Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 74: 179–184, 2001
    1. Hebbel RP, Osarogiagbon R, Kaul D: The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation 11: 129–151, 2004
    1. Nath KA, Katusic ZS, Gladwin MT: The perfusion paradox and vascular instability in sickle cell disease. Microcirculation 11: 179–193, 2004
    1. Kato GJ, Gladwin MT, Steinberg MH: Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21: 37–47, 2007
    1. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, Katusic ZS: Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 279: R1949–R1955, 2000
    1. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S: Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 97: 1584–1589, 2001
    1. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT: Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol 84: 618–625, 2009
    1. Morris CR: Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology (Am Soc Hematol Educ Program) 2008: 177–185, 2008
    1. Wood KC, Hsu LL, Gladwin MT: Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med 44: 1506–1528, 2008
    1. Juncos R, Juncos L, Hebbel RP, Vercellotti GM, Katusic ZS, Nath KA: Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease. J Cardiovasc Pharmacol 57: 263–266, 2011
    1. Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL: Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest 118: 1924–1933, 2008
    1. Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, Vercellotti GM, Hebbel RP, Katusic ZS, Terzic A, Nath KA: Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiol 301: F845–F851, 2011
    1. Enenstein J, Milbauer L, Domingo E, Wells A, Roney M, Kiley J, Wei P, Hebbel RP: Proinflammatory phenotype with imbalance of KLF2 and RelA: Risk of childhood stroke with sickle cell anemia. Am J Hematol 85: 18–23, 2010
    1. Falk RJ, Jennette JC: Sickle cell nephropathy. Adv Nephrol Necker Hosp 23: 133–147, 1994
    1. Saborio P, Scheinman JI: Sickle cell nephropathy. J Am Soc Nephrol 10: 187–192, 1999
    1. Guasch A, Navarrete J, Nass K, Zayas CF: Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17: 2228–2235, 2006
    1. Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV: High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 21: 413–417, 2010
    1. Hostetter TH: Hyperfiltration and glomerulosclerosis. Semin Nephrol 23: 194–199, 2003
    1. Nath KA, Croatt AJ, Hostetter TH: Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258: F1354–F1362, 1990
    1. Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R: Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol 25: 2123–2127, 2010
    1. Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F: Glomerular hyperfiltration in adult sickle cell anemia: A frequent hemolysis associated feature. Clin J Am Soc Nephrol 5: 756–761, 2010
    1. Maier-Redelsperger M, Lévy P, Lionnet F, Stankovic K, Haymann J-P, Lefèvre G, Avellino V, Perol J-P, Girot R, Elion J: Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia. Blood Cells Mol Dis 45: 289–292, 2010
    1. Hirschberg R: Glomerular hyperfiltration in sickle cell disease. Clin J Am Soc Nephrol 5: 748–749, 2010
    1. Ataga KI, Brittain JE, Moore D, Jones SK, Hulkower B, Strayhorn D, Adam S, Redding-Lallinger R, Nachman P, Orringer EP: Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: Potential role of soluble fms-like tyrosine kinase-1. Eur J Haematol 85: 257–263, 2010
    1. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL: Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 83: 15–18, 2008
    1. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, 3rd, Schechter AN, Gladwin MT: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8: 1383–1389, 2002
    1. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, Hebbel RP: Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893–903, 2001
    1. Tracz MJ, Alam J, Nath KA: Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18: 414–420, 2007
    1. Kanakiriya SK, Croatt AJ, Haggard JJ, Ingelfinger JR, Tang SS, Alam J, Nath KA: Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol 284: F546–F554, 2003
    1. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G: Heme degradation and vascular injury. Antioxid Redox Signal 12: 233–248, 2010
    1. Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J, Nath KA: Heme: A determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 286: F370–F377, 2004
    1. Nath KA, Grande JP, Croatt AJ, Frank E, Caplice NM, Hebbel RP, Katusic ZS: Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 166: 963–972, 2005
    1. Juncos JP, Grande JP, Croatt AJ, Hebbel RP, Vercellotti GM, Katusic ZS, Nath KA: Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. Am J Physiol Renal Physiol 298: F892–F899, 2010
    1. Sklar AH, Perez JC, Harp RJ, Caruana RJ: Acute renal failure in sickle cell anemia. Int J Artif Organs 13: 347–351, 1990
    1. Guvenc B, Aikimbaev K, Unsal C, Akgul E, Akgul AE, Binokay F, Besena A: Renal vascular resistance in sickle cell painful crisis. Int J Hematol 82: 127–131, 2005
    1. Kimmelsteil P: Vascular occlusion and ischemic infarction in sickle cell disease. Am J Med Sci 216: 11–19, 1948
    1. al Ani O, Baqi N: Clinical quiz. Cortical infarction secondary to intravascular sickling in the renal cortex. Pediatr Nephrol 13: 267–268, 1999
    1. Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA: Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 300: F721–F733, 2011

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다